BioResponse   Report issue

For profit Phase 1
Founded: Boulder CO United States (1998)
Status: Left NME R&D (2019)

Organization Overview

First Clinical Trial
2009
NCT01022333
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2009

Timeline

NOW
  • Now